191
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Cyclosporin A pre‐incubation attenuates hypoxia/reoxygenation‐induced apoptosis in mesenchymal stem cells

, , , , , , , & show all
Pages 585-593 | Received 09 May 2007, Accepted 28 Dec 2007, Published online: 08 Jul 2009
 

Abstract

Although mesenchymal stem cells (MSCs) are being tested for cardiac repair, the majority of transplanted cells undergo apoptosis in the ischaemic heart because of the effects of ischaemia/reperfusion, poor blood supply and other pro‐apoptotic factors. Several experimental and clinical studies have suggested that cyclosporin A (CsA) treatment reduces apoptosis in human endothelial cells and neurocytes. However, the effect of CsA on the apoptosis in MSCs is still unclear. In this study, we investigated whether CsA could inhibit hypoxia/reoxygenation (H/R)‐induced apoptosis in MSCs. MSCs pre‐incubated with or without CsA were subjected to 6 h of hypoxia followed by 12 h of reoxygenation. Our data showed that pre‐incubation with 0.5–5 µM CsA dose‐dependently protected the MSCs from H/R injury, as evidenced by decreased apoptosis and increased cell viability. CsA inhibited the H/R‐induced translocation of cytochrome c, increased bcl‐2 expression and restored mitochondrial membrane potential. CsA also increased the expression of p‐BAD. We propose that pre‐incubation MSCs with CsA inhibits MSC apoptosis through the mitochondrial and BAD pathway.

Acknowledgements

We are indebted to Jun Jiang for expert review of the manuscript and to Ping Chen and Jiang Cao for technical assistance. The work was supported in part through grants from the National Natural Science Foundation of China (no. 30670868) and from the Zhejiang province Natural Science Foundation (no. R206007). Tie‐long Chen and Jian‐an Wang contributed equally to the study.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.